{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:36:41Z","timestamp":1771475801786,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005358","name":"ACMG Foundation for Genetic and Genomic Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ymgmr.2021.100791","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T17:17:58Z","timestamp":1629739078000},"page":"100791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Creatine metabolism in patients with urea cycle disorders"],"prefix":"10.1016","volume":"29","author":[{"given":"Filippo","family":"Ingoglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Leon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2021.100791_bb0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","article-title":"Urea cycle disorders-update","volume":"64","author":"Matsumoto","year":"2019","journal-title":"J. Hum. Genet."},{"issue":"815\u2013830","key":"10.1016\/j.ymgmr.2021.100791_bb0010","first-page":"vi","article-title":"Urea cycle disorders","volume":"4","author":"Burton","year":"2000","journal-title":"disordersClin. Liver Dis."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000468779","article-title":"Hepatocyte heterogeneity in the metabolism of amino acids and ammonia","volume":"46","author":"Haussinger","year":"1992","journal-title":"Enzyme"},{"issue":"Suppl 1","key":"10.1016\/j.ymgmr.2021.100791_bb0020","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ymgme.2010.02.011","article-title":"Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine","volume":"100","author":"Braissant","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-007-0709-5","article-title":"Neurological implications of urea cycle disorders","volume":"30","author":"Gropman","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30292","article-title":"Disorders of creatine transport and metabolism","volume":"157C","author":"Longo","year":"2011","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"issue":"Suppl 1","key":"10.1016\/j.ymgmr.2021.100791_bb0035","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ymgme.2010.01.012","article-title":"Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia","volume":"100","author":"Deignan","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymgme.2007.09.016","article-title":"Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia","volume":"93","author":"Deignan","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-1-4757-6903-6_52","article-title":"Guanidino compounds in hyperargininemia","volume":"153","author":"Marescau","year":"1982","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0009-8981(85)90120-2","article-title":"Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy","volume":"146","author":"Marescau","year":"1985","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10545-016-9928-y","article-title":"Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency","volume":"39","author":"Huemer","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10545-012-9494-x","article-title":"Creatine metabolism in urea cycle defects","volume":"35","author":"Boenzi","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/mgme.2001.3257","article-title":"Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation","volume":"74","author":"Schulze","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10545-013-9662-7","article-title":"Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency","volume":"37","author":"Pasquali","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2013.08.020","article-title":"Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency","volume":"110","author":"Viau","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2015.01.008","article-title":"Quantitative amino acid analysis by liquid chromatography-tandem mass spectrometry: implications for the diagnosis of argininosuccinic aciduria","volume":"442","author":"De Biase","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ymgme.2019.02.003","article-title":"Additional individual contributors from, decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: options for treatment","volume":"126","author":"Molema","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2014.06.005","article-title":"Members of the urea cycle disorders, S.C. nagamani, sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders","volume":"113","author":"Burrage","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejpn.2018.02.007","article-title":"Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: an international retrospective cohort study","volume":"22","author":"Khaikin","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/dmcn.12488","article-title":"Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring","volume":"56","author":"Amayreh","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0105","series-title":"GeneReviews((R))","article-title":"Arginase deficiency","author":"Wong","year":"1993"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0110","doi-asserted-by":"crossref","first-page":"F1799-1804","DOI":"10.1152\/ajprenal.00356.2007","article-title":"Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo","volume":"293","author":"Edison","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0115","doi-asserted-by":"crossref","first-page":"12034","DOI":"10.1016\/S0021-9258(20)71316-5","article-title":"Repression of rat kidney L-arginine:glycine amidinotransferase synthesis by creatine at a pretranslational level","volume":"259","author":"McGuire","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0120","series-title":"The Molecular and Metabolic Bases of Inherited Disease","first-page":"1909","article-title":"SW, Urea enzymes","author":"Brusilow","year":"2001"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymgme.2004.04.009","article-title":"Guanidinoacetate and creatine\/creatinine levels in controls and patients with urea cycle defects","volume":"82","author":"Arias","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0005-2744(80)90194-1","article-title":"Inhibition of arginine-glycine amidinotransferase by ornithine.\u00a0 A possible mechanism for the muscular and chorioretinal atrophies in gyrate atrophy of the choroid and retina with hyperornithinemia","volume":"613","author":"Sipila","year":"1980","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1212\/WNL.53.2.303","article-title":"Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia","volume":"53","author":"Nanto-Salonen","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2021.100791_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2008.12.010","article-title":"Secondary creatine deficiency in ornithine delta-aminotransferase deficiency","volume":"97","author":"Valayannopoulos","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcn\/85.1.19","article-title":"Methyl balance and transmethylation fluxes in humans","volume":"85","author":"Mudd","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20150837","article-title":"Division of labour: how does folate metabolism partition between one-carbon metabolism and amino acid oxidation?","volume":"472","author":"Brosnan","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgmr.2021.100791_bb0155","series-title":"GeneReviews((R))","article-title":"Argininosuccinate lyase deficiency","author":"Nagamani","year":"1993"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:52:28Z","timestamp":1762001548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426921000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":31,"alternative-id":["S2214426921000859"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100791","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creatine metabolism in patients with urea cycle disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100791"}}